UNIQA Insurance Group AG Overview
UNIQA Insurance Group is Austria's second-largest insurance group, with a domestic market share of roughly 21% and a dominant position of around 44% in Austrian private health insurance, combined with a meaningful multi-line franchise across eleven Central and Eastern European markets plus Switzerland and Liechtenstein. Following the 2020 acquisition of AXA's Polish, Czech and Slovak businesses and the 2024–25 exits from Russia and the ALMAKOS markets (Albania, Kosovo, North Macedonia), the group is a more concentrated, higher-margin CE-weighted insurer. In FY2025 it wrote EUR 8.35bn of premiums, generated EUR 7.12bn insurance revenue and EUR 516m pre-tax profit, and carries a Solvency II ratio of about 275%. Its "UNIQA 3.0 – Growing Impact" programme (2025–2028) targets 6% annual premium growth, a net combined ratio of at most 93%, at least 7% annual earnings growth and a progressive dividend. Control rests with a stable Austrian core-shareholder syndicate, and UNIQA also holds a significant equity-accounted stake in construction group STRABAG.
What the company does
UNIQA is a composite (multi-line) primary insurer with an internal and increasingly external reinsurance carrier. It underwrites three business lines — property and casualty (P&C), health, and life — and distributes them through tied agents and exclusive sales partners, brokers, bancassurance (most importantly the Raiffeisen banking network in Austria, operated under the Raiffeisen Insurance brand, and banks in CEE), and direct/digital channels. Beyond risk-carrying, the group runs an asset-management capability (UNIQA Capital Markets and UNIQA Real Estate Management), pension funds, a health-services platform branded Mavie (telemedicine, health centres, private clinics and preventive services), and shared-service and IT units including a Group Service Centre in Nitra (Slovakia) and a technology hub in Belgrade (sTech).
Company self-description (Group Report 2025)
The group describes itself as one of the leading insurance groups in its core markets of Austria and CEE, with over 21,000 employees and exclusive sales partners serving its customers, the second-largest insurance group in Austria with a market share of about 21%, and — under its brand line "living better together" — positions its ambition as becoming more than an insurer: the best service provider for safety, health and prevention in people's lives (UNIQA strategy page; Group Report 2025, "What we want to be: More than just an insurance company").
Revenue model
| Revenue component | Nature | FY2025 (EUR Mn) | Share of total insurance revenue |
|---|---|---|---|
| P&C insurance revenue | Annual/renewable premiums (motor, property, liability, accident, commercial) — recurring, quasi-subscription | 4,774.6 | 67.1% |
| Health insurance revenue | Long-term private health contracts (largely Austria) — recurring, CSM-driven | 1,449.8 | 20.4% |
| Life insurance revenue | Traditional, unit-linked and index-linked life — long-duration, CSM release-driven | 891.1 | 12.5% |
| Net investment income (incl. equity-method STRABAG) | Investment spread on EUR 21.1bn portfolio | 798.8 | n/a (below revenue line) |
| Other income (services, asset management fees, health services) | Fee-based | 452.9 | — |
Source: Group Report 2025, Group business development. Percentages derived.
The economic model is therefore "service/subscription-like" (insurance premiums renew annually or run for long durations) rather than product sale or licensing. Profit comes from three sources: underwriting margin (insurance service result EUR 710.8m in FY2025), investment spread (financial result EUR 209.4m after allocating finance expenses to policyholders), and fee income, offset by a non-technical result of EUR –325.9m (other expenses including holding costs, interest and amortisation).
Value-chain position
UNIQA sits in the risk-carrying core of the insurance value chain (product design, pricing, underwriting, claims, reserving, capital), owns substantial parts of distribution (tied agents, captive Raiffeisen bancassurance relationship in Austria), has vertically integrated into health-care delivery via Mavie and private clinics, and has moved upstream into reinsurance through UNIQA Re AG (Zurich), which writes both intra-group cessions and a growing external reinsurance book (5% of group premiums in 6M25; 4% in FY25 per the FY25 presentation).
Customer types and end-markets
Retail/personal lines: households (motor, home, accident, life, private health) — the bulk of the book in both Austria and CEE.
SME and commercial lines: commercial property, liability, motor fleets, group health and group life.
Corporate/industrial: larger commercial risks, art insurance (a named Executive Board responsibility).
Bancassurance customers: via Raiffeisen in Austria and partner banks in CEE.
Reinsurance clients: third-party cedants of UNIQA Re.
Independent characterisation
UNIQA is best understood as two businesses sharing a balance sheet: (1) a mature, cash-generative Austrian franchise with an unusually valuable private-health back book (Austria Health CSM of about EUR 4bn of a EUR 5.8bn group CSM at FY25), whose profits are earned slowly and predictably; and (2) a faster-growing CEE P&C and life platform, now concentrated on CE markets (Poland, Czechia, Slovakia, Hungary), which produces the majority of incremental growth. Overlaid on these is a third, more volatile earnings driver — investment income including the equity-accounted STRABAG stake (EUR 206.5m contribution in FY2025) — and a newer, cyclically exposed external reinsurance business. The equity story since 2024 has been margin expansion (net combined ratio from 93.1% to 91.7%), portfolio pruning (Russia, ALMAKOS) and dividend progression.
Strategy
Stated strategy
UNIQA's strategic programme "UNIQA 3.0 – Growing Impact" (2025–2028), presented at the London Capital Markets Day in December 2024 and upgraded at the Capital Market Update in London on 27 November 2025, builds on "UNIQA 3.0 – Seeding the Future" (2021–2024). Its stated themes are profitable growth, further efficiency improvements, and expansion of the group's position in Austria and CEE — described by management as the world's fastest-growing insurance region — with growth "driven primarily by property and casualty insurance and health insurance" (Group Report 2024). The ambition is to translate continued high investment faster and better into customer satisfaction, growth and earnings, and three goals are set for 2028 around customers, employees ("the best employer for impact-driven employees") and financial self-determination (UNIQA strategy page). Customer and employer performance is measured by indices targeting 4.5 of 5 stars each.
Medium-term financial targets
| Target | Original (Dec 2024) | Upgraded (Nov 2025, for 2026–2028) |
|---|---|---|
| Premium growth | c.5% p.a. average | c.6% p.a. (Austria c.4%, International c.8%) |
| Net combined ratio | Consistently below 94% | At most 93% |
| Earnings growth | Consolidated profit growth above 6% p.a. | At least 7% p.a. (EPS) |
| Return on equity | Stable above 12% | Stable above 13% |
| Solvency II ratio | — | 180–230% corridor by 2028 |
| CSM sustainability ratio | c.90% by 2028 | c.90% by 2028 (78.2% in Q1 2026) |
| Dividend | Annually increasing DPS | Progressive DPS within 50–60% payout |
Sources: xprimm (Dec 2024); UNIQA IR news 27 Nov 2025; CEO foreword Group Report 2025; Q1 2026 call.
2026 guidance: EBT of EUR 540–570m, barring exceptional NatCat or capital-market disruption; premium growth above GDP growth in its markets; 50–60% payout with an annually rising DPS (FY25 results, reaffirmed at Q1 and H1 2026). By mid-year, c.60% of the midpoint had been earned (news.at/APA).
Strategic initiatives (last 24 months)
| Initiative | Description | Status |
|---|---|---|
| Portfolio pruning | Exit Russia (2024) and ALMAKOS (Q2 2025) | Complete |
| CE growth push | Focus on Poland, Czechia, Slovakia, Hungary; strategic emphasis on SEE synergies (Montenegro visit by Kindl) | Ongoing |
| External reinsurance build-out | UNIQA Re writing third-party business; main driver of 2026 P&C premium growth | Ongoing; questioned by some analysts given softening reinsurance pricing (AlphaValue, May 2026) |
| Health ecosystem (Mavie) | Telemedicine, health centres, private clinics, prevention; first dental partner centre (H4O, 2026) | Expanding |
| Digitalisation and AI | Investments in IT and AI noted on FY25 call; c.86% of health claims notifications processed digitally; AI in endoscopy referenced in AGM 2026 materials | Ongoing |
| Capital structure | S&P upgrade; 2026 Tier 2 refinancing (EUR 500m new issue, tender and early call) | Executed |
| Sustainability | Paris 1.5°C commitment; PCAF membership (Jun 2025); CDP A–; green bond | Ongoing |
| Cost discipline | Admin cost ratio down to 15.3% (FY25) despite IT spend | Ongoing |
No formal standalone cost-cutting programme with a euro target was identified.
Products & Services
UNIQA does not publish a product-by-product revenue catalogue; the following is organised by segment and line, drawing on Group Report disclosures and brand descriptions. Pricing is premium-based and risk-rated; individual tariffs are not disclosed in filings.
UNIQA Austria
| Product line / brand | Description and capabilities | Target customer | Notes / flagship |
|---|---|---|---|
| Motor insurance (MTPL, casco) | Compulsory third-party liability and comprehensive/partial casco; vehicle registration services at regional offices (e.g., integrated registration office at UNIQA Salzburg regional office) | Retail, SME fleets | Salzburg office opened/relocated near Europark (Group Report 2025 highlights) |
| Household and home insurance | Building and contents cover, natural-hazard extensions, assistance | Retail homeowners/tenants | Exposed to storm/flood (e.g., storm Boris 2024) |
| Personal accident | Accident cover, disability benefits | Retail, families | Part of Personal Lines responsibility (René Knapp) |
| Liability | Private and professional liability | Retail, professionals | — |
| Commercial and industrial property/liability | Property, business interruption, liability, engineering | SMEs, corporates | — |
| Art insurance | Specialist cover for collectors, museums and galleries | HNWI, institutions | Named group responsibility in governance disclosures |
| Private health insurance (supplementary, "Sonderklasse" hospital cover, outpatient) | Long-term private health contracts complementing Austrian statutory system; c.86% of health claims notifications processed digitally | Retail, employers (group health) | c.44% market share in Austrian health (CMD Dec 2024) |
| Mavie (health ecosystem) | Telemedicine, health centres, private clinics, preventive services; vision of making healthcare accessible | Policyholders and wider public | First dental partner centre with H4O Dental Life Center, Vienna-Floridsdorf (2026) |
| Private clinics (PremiQaMed group, under Mavie) | Private hospital operations in Austria | Privately insured patients | — |
| Traditional life insurance | Endowment and savings life with guarantees | Retail savers | Austria life premiums EUR 888.0m in 2025 |
| Unit-linked and index-linked life | Investment-type life; FINANCE LIFE brand specialises in unit-linked | Retail investors | Savings portions counted in premiums written |
| Risk life / term | Mortality protection | Retail, mortgage borrowers | — |
| Raiffeisen Insurance (bancassurance brand) | Full product suite sold via Raiffeisen banks | Raiffeisen bank customers | Led by Sabine Pfeffer since April 2023 |
| Salzburger Landes-Versicherung | Regional composite insurer (wholly owned) | Salzburg region | — |
| Pension funds / occupational pensions | Pension fund management | Employers, employees | Part of Group Asset Management |
| UNIQA Sustainable Business Solutions | Advisory/solutions on sustainability for business clients | Corporates/SMEs | Mentioned in SFCR 2025 |
UNIQA International
| Market cluster | Product focus | Notes |
|---|---|---|
| Poland (largest CEE unit) | Motor (strong retail motor growth, both volume and price), property, life, bancassurance | Poland premiums +25% in Q1 2025 on retail motor; UNIQA Poland rated A+ by S&P since Nov 2025 |
| Czechia, Slovakia | Composite P&C and life; ex-AXA businesses integrated | CE region EBT EUR 216.5m in 2025 |
| Hungary | Composite, notable life/unit-linked | Strong international growth contributor (FY25 call) |
| Romania | General insurance (non-motor emphasis, home), life | H1 2026 GWP +8% to EUR 84m, statutory PBT c.EUR 11m (revistabiz, 23 Sep 2026) |
| Ukraine | P&C, life, health | Continued operation despite war; strong growth cited in FY25 call |
| Bulgaria, Croatia, Serbia, Bosnia and Herzegovina, Montenegro (SEE) | Composite retail P&C and life | SEE EBT EUR 24.3m in 2025 |
| Switzerland, Liechtenstein (WE) | Niche life and non-life (UNIQA Versicherung AG, Vaduz) | WE EBT EUR 1.7m in 2025 |
International health premiums were EUR 134.2m in 2025 (a small line); international life premiums EUR 811.2m; international P&C EUR 2,408.4m.
Reinsurance
| Offering | Description |
|---|---|
| Intra-group reinsurance | UNIQA Re AG, Zurich, pools and retrocedes group risks, including natural catastrophe protection |
| External (third-party) reinsurance | Growing book written for external cedants; responsible for much of the 19.5% P&C premium growth in Q1 2026 (AlphaValue) and highlighted as a growth driver in H1 2026 |
Group-level services
| Service | Description |
|---|---|
| UNIQA Capital Markets (UCM) | Group investment management of the c.EUR 21bn portfolio |
| UNIQA Real Estate Management (UREM) | Real-estate investment and management |
| UNIQA Ventures | Corporate venture investments (named strategic responsibility) |
| Group Service Centre Nitra (Slovakia) | Shared operations and back-office |
| sTech d.o.o., Belgrade | IT/tech services hub |
Financial Narrative
Income statement — management KPIs
FY2021 and FY2022 are IFRS 4 (as originally reported); FY2023–FY2025 are IFRS 17/9. Premiums written are on a comparable volume basis but FY2024–FY2025 exclude ALMAKOS.
Sources and notes: FY2021 premiums derived from the 3.9% growth reported for FY2022 (EUR 6,605.2m); FY2021–FY2022 EBT and EPS from Group Report 2022 (IFRS 4); FY2022 IFRS 17 insurance revenue and operating profit, FY2021–FY2023 tax and FY2023 operating profit from stockanalysis.com (aggregator; restated IFRS 17 basis for 2022 and original basis for 2021); FY2021 and FY2022 net profit derived as EPS × c.307m shares (approximate); FY2023 EPS derived as net profit / 306.97m shares; FY2023–FY2025 all other data from Group Report 2025; dividends from finanzen.ch dividend calendar and Group Report 2025.
Gross profit, EBITDA, gross margin, EBITDA margin: N/M for insurers (UNIQA does not report them). The insurance service result is the closest analogue to gross profit.
Margins and growth (derived)
FY2022 margins mix IFRS 4 earnings with IFRS 17 revenue and are indicative only. FY2024 and FY2025 effective tax rates as reported (21.2% and 18.0%); others derived.
Revenue CAGR: Premiums written FY2021–FY2025: c.7.1% p.a. (derived; scope changed by ALMAKOS exclusion in 2024–25, which depresses the comparable growth rate, i.e., organic CAGR is somewhat higher). Insurance revenue FY2023–FY2025: c.9.0% p.a. (derived).
Commentary. Three inflections stand out. First, 2025 was an underwriting year: the group insurance service result rose 26.8% to EUR 710.8m as the gross combined ratio fell to 89.2% on the "virtual absence of natural disasters" (Group Report 2025), compared with 2024 when storm Boris cost about EUR 80m net. Second, investment income has become a larger driver: net investment income rose from EUR 588.8m (2023, derived) to EUR 798.8m (2025), and the equity-method STRABAG contribution jumped from EUR 119.7m to EUR 206.5m. Third, below the technical line, the non-technical result deteriorated from EUR –254.5m to EUR –325.9m as other expenses rose 14.6%, partly reflecting IT and AI investment (FY25 call). Health EBT fell sharply in 2024 (to EUR 10.3m) before recovering to EUR 31.9m in 2025 and accelerating in Q1 2026 (EUR 26m vs EUR 2m in Q1 2025), illustrating sensitivity of the health line's IFRS 17 financial result to rates. Life EBT jumped 46.3% in 2025 on higher CSM release and lower cost ratio.
Balance sheet
Sources: Group Report 2025 (group business development; auditor's report for insurance liabilities of EUR 22,897m = 78% of total assets; bonds section for subordinated debt).
Debt structure. At 31 December 2025 UNIQA had two subordinated bonds outstanding with a total nominal of about EUR 700m and a weighted average coupon of 4.06%; EUR 375m of this is a green bond (Group Report 2025).
Cash flow
Sources: Group Report 2025; dividends paid derived as prior-year DPS × c.306.97m shares (FY2021 DPS paid in 2022, etc.). Capex / free cash flow: not separately disclosed in sources reviewed; for insurers, operating cash flow is distorted by investment flows and is not a reliable FCF proxy. An aggregator (getquin) shows FCF of EUR 971m (TTM). Buybacks: no share buyback programme identified in the period.
Ratios
Sources: Group Report 2025 (ROE, cost ratios, solvency 275% "+11pp vs end-2024" implying 264%, CSM sustainability ratio per CEO foreword); interest expense from stockanalysis.com (EUR 44.4m 2025, 48.4m 2024, 51.4m 2023). ROIC, current ratio, net debt/EBITDA, asset turnover and cash conversion cycle: N/M for an insurer. H1 2026 ROE was 16.3% and Solvency II ratio 271%.
Commentary. Capital strength is the defining balance-sheet feature: a 275% Solvency II ratio at FY25 sits well above the new 180–230% target corridor, signalling meaningful excess capital that management has so far channelled into growth (notably external reinsurance) and dividends rather than buybacks. CSM growth of 10% to EUR 5.88bn — 67% of it in Austrian health — gives high visibility on future profit release. Leverage is moderate and falling in relative terms, a factor S&P cited ("successful deleveraging") in the November 2025 upgrade.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | What it contains | Main entities/brands |
|---|---|---|
UNIQA Austria | All Austrian primary insurance across P&C, health, life | UNIQA Österreich Versicherungen AG; Raiffeisen Insurance brand (bancassurance); Salzburger Landes-Versicherung AG; FINANCE LIFE (unit-linked life) |
UNIQA International | Primary insurance in CEE and Western Europe (Switzerland, Liechtenstein), reported by region: Central Europe (CE: Czechia, Hungary, Poland, Slovakia); Eastern Europe (EE: Romania, Ukraine); Southeastern Europe (SEE: Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Serbia — ALMAKOS until sale in Q2 2025); Western Europe (WE) | UNIQA Towarzystwo Ubezpieczeń (Poland), UNIQA pojišťovna (Czechia), UNIQA Biztosító (Hungary), UNIQA Asigurări (Romania), UNIQA Versicherung AG (Vaduz) and others |
Reinsurance | UNIQA Re AG (Zurich) and the reinsurance business of UNIQA Insurance Group AG; includes growing external (third-party) reinsurance | UNIQA Re AG |
Group Functions and Consolidation | Holding, group functions, equity-method investments (incl. STRABAG), consolidation entries | UNIQA Insurance Group AG |
Revenue by Segment
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
UNIQA Austria premiums written (EUR Mn) | 4,290.0 | 4,488.3 | 4,702.9 |
UNIQA International premiums written (EUR Mn) | 2,682.2 | 3,054.8 | 3,353.8 |
Reinsurance and consolidation residual, derived (EUR Mn) | 107.9 | 176.8 | 298.0 |
Group premiums written (EUR Mn) | 7,080.1 | 7,719.9 | 8,354.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment — UNIQA Austria insurance revenue
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
UNIQA Austria insurance revenue (EUR Mn, 2023 derived from lines) | 3,519.0 | 3,720.0 | 3,947.6 |
UNIQA International insurance revenue (EUR Mn, 2023 derived from lines) | 2,429.8 | 2,755.0 | 3,054.0 |
Reinsurance, group functions and consolidation residual, derived (EUR Mn) | 45.3 | 82.2 | 113.9 |
Group insurance revenue (EUR Mn) | 5,994.1 | 6,557.2 | 7,115.5 |
Segment growth and mix (%)
| Segment growth and mix (%) | FY2024 | FY2025 |
|---|---|---|
UNIQA Austria insurance revenue YoY growth (%) | 5.7 | 6.1 |
UNIQA International insurance revenue YoY growth (%) | 13.4 | 10.9 |
UNIQA Austria share of group insurance revenue (%) | 56.7 | 55.5 |
UNIQA International share of group insurance revenue (%) | 42.0 | 42.9 |
Revenue by Segment — UNIQA Austria EBT
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
UNIQA Austria EBT (EUR Mn) | 279.2 | 313.0 | 358.4 |
UNIQA International EBT (EUR Mn) | 229.8 | 214.4 | 246.4 |
Reinsurance plus Group Functions and Consolidation, derived residual (EUR Mn) | -82.6 | -85.5 | -88.4 |
Group EBT (EUR Mn) | 426.4 | 441.9 | 516.4 |
Segment pre-tax margin on insurance revenue (derived)
| Segment pre-tax margin on insurance revenue (derived) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
UNIQA Austria EBT margin (%) | 7.9 | 8.4 | 9.1 |
UNIQA International EBT margin (%) | 9.5 | 7.8 | 8.1 |
Group EBT margin (%) | 7.1 | 6.7 | 7.3 |
Revenue by Segment (%)
| Ratio | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
UNIQA Austria combined ratio gross (%) | 92.3 | 91.9 | 92.4 |
UNIQA Austria combined ratio net (%) | 95.0 | 95.2 | 95.6 |
UNIQA Austria admin expense ratio (%) | 13.5 | 13.5 | 13.3 |
UNIQA International combined ratio gross (%) | 85.6 | 89.0 | 85.9 |
UNIQA International combined ratio net (%) | 91.6 | 92.6 | 92.3 |
UNIQA International admin expense ratio (%) | 15.5 | 15.5 | 14.9 |
Group combined ratio gross (%) | 89.4 | 91.1 | 89.2 |
Group combined ratio net (%) | 92.8 | 93.1 | 91.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment by Line Metric
| Line metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
P&C premiums written (EUR Mn) | 4,133.7 | 4,587.0 | 5,044.7 |
P&C insurance revenue (EUR Mn) | 4,006.3 | 4,421.8 | 4,774.6 |
P&C insurance service result (EUR Mn) | 287.5 | 306.2 | 396.3 |
P&C EBT (EUR Mn) | 211.5 | 281.0 | 264.2 |
Health premiums written (EUR Mn) | 1,378.0 | 1,514.5 | 1,609.5 |
Health insurance revenue (EUR Mn) | 1,234.7 | 1,355.8 | 1,449.8 |
Health insurance service result (EUR Mn) | 122.0 | 99.8 | 114.8 |
Health EBT (EUR Mn) | 44.1 | 10.3 | 31.9 |
Life premiums written incl. savings (EUR Mn) | 1,568.3 | 1,618.4 | 1,700.4 |
Life insurance revenue (EUR Mn) | 753.1 | 779.6 | 891.1 |
Life insurance service result (EUR Mn) | 152.8 | 154.5 | 199.7 |
Life EBT (EUR Mn) | 170.8 | 150.5 | 220.2 |
Business Lines
| Line | Austria IR 2024 | Austria IR 2025 | Austria EBT 2024 | Austria EBT 2025 | Intl IR 2024 | Intl IR 2025 | Intl EBT 2024 | Intl EBT 2025 |
|---|---|---|---|---|---|---|---|---|
P&C | 2,241.3 | 2,348.4 | 182.3 | 200.7 | 2,099.2 | 2,313.5 | 95.6 | 118.3 |
Health | 1,224.1 | 1,313.5 | 50.8 | 64.9 | 131.7 | 136.3 | 0.7 | 7.9 |
Life | 254.6 | 285.6 | 79.9 | 92.8 | 524.1 | 604.2 | 118.1 | 120.2 |
Revenue by Segment and Per-Share Data
| Metric | H1 2025 | H1 2026 | Change |
|---|---|---|---|
Premiums written incl. savings (EUR Mn) | 4,397.2 | 4,924.2 | +12.0% |
of which P&C (EUR Mn) | 2,723.2 | 3,163.3 | +16.2% |
of which health (EUR Mn) | 811.3 | 875.3 | +7.9% |
of which life (EUR Mn) | 862.7 | 885.6 | +2.6% |
UNIQA Austria premiums (EUR Mn) | 2,486.7 | 2,591.1 | +4.2% |
UNIQA International premiums (EUR Mn) | 1,705.9 | 1,823.0 | +6.9% |
Insurance revenue (EUR Mn) | 3,498.8 | 3,773.8 | +7.9% |
Insurance service result (EUR Mn) | c.378 | 359.9 | –4.9% |
Financial result (EUR Mn) | 88.2 | 176.4 | +100% |
EBT (EUR Mn) | 295.5 | 326.5 | +10.5% |
Net profit attributable (EUR Mn) | 232.5 | 258.4 | +11.1% |
EPS (EUR) | 0.76 | 0.84 | +10.5% |
Net combined ratio (%) | 90.5 | 91.6 | +1.1pp |
ROE after tax and minorities (%) | 15.7 | 16.3 | +0.6pp |
Solvency II ratio (%) | — | 271 | — |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Premiums written incl. savings portions (EUR Mn) | 6,357.0 | 6,605.2 | 7,080.1 | 7,719.9 | 8,354.7 |
Insurance revenue IFRS 17 (EUR Mn) | — | 5,347.0 | 5,994.1 | 6,557.2 | 7,115.5 |
Insurance service result (EUR Mn, 2023 sum of lines) | — | — | 562.3 | 560.5 | 710.8 |
Net investment income (EUR Mn, 2023 sum of lines) | — | — | 588.8 | 749.7 | 798.8 |
Financial result (EUR Mn, 2023 sum of lines) | — | — | 150.2 | 210.2 | 209.4 |
Operating profit (EUR Mn) | — | 352.4 | 506.1 | 516.2 | 594.2 |
Earnings before taxes (EUR Mn) | 382.3 | 421.7 | 426.4 | 441.9 | 516.4 |
Income tax (EUR Mn) | 64.4 | 16.9 | 103.2 | 93.7 | 93.1 |
Net profit attributable to shareholders (EUR Mn) | 316.0 | 384.0 | 302.7 | 347.6 | 424.8 |
EPS basic = diluted (EUR) | 1.03 | 1.25 | 0.99 | 1.13 | 1.38 |
Dividend per share for the fiscal year (EUR) | 0.55 | 0.55 | 0.57 | 0.60 | 0.72 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Premiums written growth (%) | — | 3.9 | 7.2 | 9.0 | 8.2 |
Insurance revenue growth (%) | — | — | 12.1 | 9.4 | 8.5 |
Insurance service margin on insurance revenue (%) | — | — | 9.4 | 8.5 | 10.0 |
Operating margin on insurance revenue (%) | — | 6.6 | 8.4 | 7.9 | 8.4 |
EBT margin on insurance revenue (%) | — | 7.9 | 7.1 | 6.7 | 7.3 |
Net margin on insurance revenue (%) | — | 7.2 | 5.1 | 5.3 | 6.0 |
Effective tax rate (%) | 16.8 | 4.0 | 24.2 | 21.2 | 18.0 |
Payout ratio (%) | 53 | 44 | 58 | 53 | 52 |
Balance Sheet and Per-Share Data
| Metric | FY2024 | FY2025 |
|---|---|---|
Total assets (EUR Mn) | 28,532.1 | 29,047.9 |
Investments incl. investment property and equity method (EUR Mn) | 20,725.5 | 21,063.6 |
Liabilities from insurance contracts (EUR Mn) | — | 22,897.0 |
Contractual service margin, CSM (EUR Mn) | 5,345.6 | 5,879.3 |
Cash and cash equivalents (EUR Mn) | 637.1 | 659.8 |
Subordinated liabilities, nominal (EUR Mn) | — | 700.0 |
Equity attributable to shareholders (EUR Mn) | 2,889.7 | 3,063.8 |
Non-controlling interests (EUR Mn) | 51.7 | 101.0 |
Book value per share (EUR, derived) | 9.41 | 9.98 |
Key Financials
| CSM by line (EUR Mn) | FY2024 | FY2025 |
|---|---|---|
P&C CSM (EUR Mn) | 93.9 | 70.1 |
Health CSM (EUR Mn) | 3,501.0 | 3,919.8 |
Life CSM (EUR Mn) | 1,750.6 | 1,889.3 |
Dividends & Capital Returns
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Net cash flow from operating activities (EUR Mn) | — | — | 580.7 | 1,137.7 |
Net cash flow from investing activities (EUR Mn) | — | — | -488.0 | -795.9 |
Net cash flow from financing activities (EUR Mn) | — | — | -153.7 | -317.4 |
Change in cash and equivalents (EUR Mn) | — | — | — | 22.6 |
Dividends paid in year, derived (EUR Mn) | 168.8 | 168.8 | 175.0 | 184.2 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
ROE after tax and minorities, reported (%) | — | 12.4 | 14.3 |
ROA on year-end assets, derived (%) | — | 1.2 | 1.5 |
Interest coverage, (EBT + interest) / interest, derived (x) | 9.3 | 10.1 | 12.6 |
Subordinated debt / shareholders' equity, derived (%) | — | — | 22.8 |
Solvency II ratio (%) | — | 264 | 275 |
Administrative expense ratio (%) | 15.7 | 15.9 | 15.3 |
Total cost ratio (%) | 31.0 | 31.2 | 31.4 |
Operating CSM sustainability ratio (%) | — | 77.9 | 81.1 |
Revenue by Region
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Austria insurance revenue (EUR Mn) | 3,519.0 | 3,720.0 | 3,947.6 |
International (CEE plus WE) insurance revenue (EUR Mn) | 2,429.8 | 2,755.0 | 3,054.0 |
Reinsurance/consolidation residual (EUR Mn, derived) | 45.3 | 82.2 | 113.9 |
Growth rates (%)
| Growth rates (%) | FY2024 | FY2025 |
|---|---|---|
Austria insurance revenue growth (%) | 5.7 | 6.1 |
International insurance revenue growth (%) | 13.4 | 10.9 |
Revenue by Region (FY2024–FY2025)
| Region | FY2024 | FY2025 |
|---|---|---|
Central Europe (CZ, HU, PL, SK) EBT (EUR Mn) | 191.6 | 216.5 |
Eastern Europe (RO, UA) EBT (EUR Mn) | 34.4 | 27.8 |
Southeastern Europe (BA, BG, HR, ME, RS; ALMAKOS pro rata to sale) EBT (EUR Mn) | 26.1 | 24.3 |
Western Europe (CH, LI) EBT (EUR Mn) | -1.0 | 1.7 |
Segment Overview — UNIQA Austria
| Segment | P&C | Health | Life | Total |
|---|---|---|---|---|
UNIQA Austria | 2,339.6 | 1,475.3 | 888.0 | 4,702.9 |
UNIQA International | 2,408.4 | 134.2 | 811.2 | 3,353.8 |
Share Price and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Year-end share price, derived from dividend yield data (EUR) | 8.06 | 7.00 | 7.46 | 7.83 | 15.46 |
Annual share price change, derived (%) | — | -13.2 | 6.6 | 5.0 | 97.4 |
Dividend per share (EUR) | 0.55 | 0.55 | 0.57 | 0.60 | 0.72 |
Dividend yield at year-end price (%) | 6.82 | 7.86 | 7.64 | 7.66 | 4.66 |
Valuation Multiples
| Multiple | UNIQA | Note |
|---|---|---|
P/E trailing FY2025 | c.12.7x | EUR 17.5 / EPS 1.38 |
P/E forward 2026 | c.11.7x | aktien.guide consensus basis; consensus EPS 2026 c.EUR 1.47 |
P/B | c.1.75x | Book value per share EUR 9.98 at YE2025 |
Dividend yield (FY2025 DPS) | c.4.1% | EUR 0.72 / 17.5 |
EV/EBITDA, EV/Sales | N/M | Not meaningful for insurers; aggregator KUV c.0.69x |
Entity / Instrument Details
| Entity / instrument | S&P rating | Since |
|---|---|---|
UNIQA Insurance Group AG (issuer credit) | A | Nov 2025 (from A–) |
UNIQA Österreich Versicherungen AG | A+ | Nov 2025 (from A) |
UNIQA Re AG | A+ | Nov 2025 (from A) |
UNIQA Towarzystwo Ubezpieczeń (Poland) | A+ | Nov 2025 |
Subordinated bonds | BBB+ | Nov 2025 |
Senior bond | A | Nov 2025 |
Capital Instruments
| Instrument | Nominal | Coupon / terms | Status |
|---|---|---|---|
Green Tier 2 subordinated bond (2020) | EUR 375m | Part of 4.06% weighted average | Outstanding |
Tier 2 subordinated bond (2015 vintage, first call 27 Jul 2026) | c.EUR 325m remaining (derived from EUR 700m total less EUR 375m green) | — | Early redemption announced June 2026 |
New Tier 2 subordinated notes (May 2026) | EUR 500m | — | Issued |
Senior bond | — | — | Outstanding (rated A) |
Analyst Conclusions
Management guidance
-
FY2026 EBT EUR 540–570m (vs. EUR 516.4m in FY2025, i.e., +5% to +10%), barring exceptional NatCat or capital-market disruption; c.60% of the midpoint earned by mid-year.
-
Premium growth above GDP growth; 2026–2028 targets: c.6% p.a. premium CAGR, net CR ≤93%, EPS growth ≥7% p.a., ROE >13%, Solvency II 180–230%, CSM sustainability ratio c.90% by 2028, progressive DPS within 50–60% payout.
Consensus expectations
Consensus EPS of c.EUR 1.47 for FY2026 (+6.5%) sits slightly below the midpoint implied by guidance, reflecting caution on H2 NatCat; consensus price targets of c.EUR 17 imply limited upside from August levels.
Bull case
-
Compounding visible earnings: a EUR 5.88bn CSM growing c.10% p.a., dominated by Austrian health, underwrites mid-to-high single-digit earnings growth with low volatility, supporting the ≥7% EPS target.
-
Excess capital optionality: Solvency II at 271% vs. a 180–230% corridor leaves room for value-accretive CE M&A, buybacks or higher payouts; the S&P upgrade lowers funding costs.
-
CE growth engine: International gross CR of 85.9% and CE EBT growth of 13% show high-margin growth that should lift the group combined ratio toward 91% as International's weight rises.
Bear case
-
Earnings quality: STRABAG's EUR 206.5m contribution and a doubled H1 2026 financial result flatter reported profit; core insurance EBT ex-STRABAG appears roughly flat in 2025 (derived).
-
Reinsurance mis-timing and NatCat: the external reinsurance build-out coincides with softening prices, while climate-driven losses (Boris 2024; structural heatwaves) could quickly erode a sub-92% combined ratio; management's own c.EUR 180m of H1 2026 reserve and NatCat provisioning signals caution.
-
Valuation already re-rated: after a 97% rise in 2025, the shares trade at c.1.75x book and near consensus targets, leaving less margin for error; Austrian P&C at 95.6% net CR remains structurally weak.
Catalysts and monitorables (next 12 months)
| Catalyst | Timing | What to watch |
|---|---|---|
| 9M 2026 results | 20 Nov 2026 | Q3 NatCat burden; release of H2 provisions; guidance tightening |
| Autumn/winter storm season | Q4 2026 | Losses vs. c.EUR 100m provision |
| Management Board mandate decision (Pfeffer) | By 31 Dec 2026 | Continuity in bancassurance |
| FY2026 preliminary results and DPS proposal | 25 Feb 2027 | EBT vs. EUR 540–570m; DPS growth (progressive policy implies >EUR 0.72) |
| Capital deployment | 2026–2027 | M&A, buyback or special dividend to address solvency surplus |
| UNIQA Re external book | Ongoing | Volume discipline and loss ratios in softening market |
| ECB/CEE rate path | Ongoing | Financial result and OCI sensitivity |
| STRABAG earnings and share price | Ongoing | Equity-method contribution |
Concluding analyst verdict
UNIQA enters the final quarter of 2026 as a materially stronger institution than it was three years ago. Portfolio simplification (exits from Russia and ALMAKOS), sustained underwriting discipline in CEE, and the steady release of a EUR 5.9bn contractual service margin have lifted ROE from 12.4% to 14.3% in FY2025 and 16.3% in H1 2026, while S&P's November 2025 upgrade to A/A+ formally recognised the improved risk profile. The "Growing Impact" programme is running ahead of plan, with the November 2025 target upgrade — 6% premium growth, a net combined ratio of at most 93%, at least 7% EPS growth — looking achievable on current run-rates, and the FY2026 EBT guidance of EUR 540–570m appears well underwritten by the EUR 326.5m earned in the first half plus explicit H2 catastrophe provisioning.
The investment debate, however, has shifted from "can UNIQA improve?" to "how much of the improvement is durable and is it already priced?" Two issues dominate. First, earnings quality: a large and rising equity-method contribution from STRABAG and a doubled financial result mean that a meaningful share of recent profit growth is investment-driven rather than technical, and the Austrian P&C book still runs a 95.6% net combined ratio. Second, capital allocation: a Solvency II ratio above 270% against a 180–230% corridor implies several hundred basis points of surplus that is currently being deployed into an external reinsurance book at a soft point in the cycle — a choice that invites scrutiny.
On balance, UNIQA is a high-quality, well-capitalised CEE insurance compounder with an attractive c.4% dividend yield and progressive payout policy, but after the 2025 re-rating to c.1.75x book and c.12x forward earnings, upside depends on demonstrating core underwriting progress in Austria and a disciplined, shareholder-friendly use of excess capital. We would characterise the risk-reward as balanced-to-positive, with the 9M 2026 results and the FY2026 capital-return decision as the key near-term tests.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role / responsibilities | Board tenure | Age (2025 report) / born | Prior roles and education |
|---|---|---|---|---|
Andreas Brandstetter | CEO; Chair of the Management Board of UNIQA Österreich; Strategy & Transformation, New Business Areas (Health/Mavie) | Board since 1 Jan 2002; CEO since 1 Jul 2011; mandate to 30 Jun 2028 | 56 / 1969 | Head of EU office of Austrian Raiffeisen Association, Brussels; doctorate in political science (Vienna and US); Executive MBA (California State University Hayward/IMADEC); Stanford GSB and Harvard Business School programmes; President of Insurance Europe 2018–2024; Supervisory Board member STRABAG SE |
Kurt Svoboda | CFRO — Finance & Risk Management (Group Performance Management, Group Risk Management) | Since 1 Jul 2011; mandate to 30 Jun 2028 | 59 / 1967 | KPMG Austria from 1992; MD UNIQA Finanz Service GmbH from 2003; CEO UNIQA Österreich Dec 2017–Jun 2020; business administration (international tax, insurance management), University of St. Gallen, Stanford GSB, HBS; represents UNIQA at the CRO Forum |
Wolfgang Kindl | Customers & Markets International | Since 2011 (reappointed 1 Jul 2020); mandate to 30 Jun 2028 | 59 / 1966 | With UNIQA since 1996; ran Geneva subsidiary 2000–2004; MD UNIQA International from 2005; Board member of Eurapco since 2024; doctorate in social and economic sciences; IMD and HBS programmes |
Peter Humer | Customers & Markets Austria (performance management, sales, customer management) | Since Jan 2020 (appointed 1 Jul 2020 per governance report); mandate to 30 Jun 2028 | 54 / 1971 | Joined UNIQA 1996 in sales; Board member Salzburger Landes-Versicherung and regional director Salzburg from 2009; Board member Sales UNIQA Österreich from 2017; doctorate in social and economic sciences; IMD and HBS; holds 17,137 UNIQA shares |
René Knapp | Asset Management (UCM/UREM/pension funds), Personal Lines, People & Brand; co-responsible for New Business Areas (Health/Mavie) | Since Jan 2020; mandate to 30 Jun 2028 | 43 / 1983 | Joined 2007; head of life actuarial 2010; Group Actuarial from 2012, expanded with Group Risk Management 2015; mathematician and actuary; AVÖ board member; HBS and MIT Sloan executive programmes |
Sabine Pfeffer | Customers & Markets Bancassurance Austria (Raiffeisen Insurance brand) | Since 1 Apr 2023; mandate to 31 Dec 2026 | 53 / 1972 | Generali from 1993; senior roles at Wiener Städtische (personal insurance administration); business administration, Master in Legal Studies, WU Executive Academy insurance management |
Wolf Gerlach | Operations and Data & IT (Group Executive Board) | Executive Board member since 2020 | 46 | Allianz Group; UNIQA International Bancassurance 2008; Head of Group Strategy 2010–2012; COO UNIQA Romania four years; Management Board Retail UNIQA Hungary from 2016; HBS. Note: Gerlach appears on the Group Executive Board page; the statutory Management Board composition list retrieved names the six members above. |
Major Shareholders
| Holder | Stake | Source |
|---|---|---|
UNIQA Versicherungsverein Privatstiftung group (of which Austria Versicherungsverein Beteiligungs-Verwaltungs GmbH 41.3%; UNIQA Versicherungsverein Privatstiftung 7.7%) | c.49.0% | Group Report 2025; MarketScreener |
Raiffeisen Bank International AG (via RZB Versicherungsbeteiligung and related vehicles) | 10.9% | MarketScreener |
Collegialität Versicherungsverein Privatstiftung | 3.7% | MarketScreener |
Treasury shares | 0.66% | MarketScreener |
Free float | c.35.6% | MarketScreener |
Competitive Landscape
Key Competitors
| Competitor | Where it competes with UNIQA | Notes |
|---|---|---|
Vienna Insurance Group (VIG; Wiener Städtische, Donau) | Austria (market leader) and across CEE (largest CEE insurer) | FY2025 GWP EUR 16.3bn; PBT EUR 1.16bn; net CR 90.1%; solvency 296% |
Generali (Generali Versicherung Austria; Generali CEE Holding) | Austria, Czechia, Poland, Hungary, Slovakia, SEE | Major multinational |
Allianz (Allianz Elementar; Allianz CEE units) | Austria, Poland, Czechia, Slovakia, Hungary, Croatia, Bulgaria | Major multinational |
PZU | Poland (market leader), Baltics | 2025 group GWP c.PLN 31bn; net profit c.PLN 6.7bn; solvency 234% |
Warta (Talanx) / HDI | Poland, Czechia | — |
Ergo (Munich Re) | Austria, Poland, Baltics | — |
Grazer Wechselseitige (GRAWE) | Austria and SEE | Mutual |
Wüstenrot / Merkur / Zurich Austria | Austrian niche/health/life competition | Merkur relevant in private health |
NN Group | Czechia, Slovakia, Poland, Hungary, Romania (life) | — |
Groupama, Kooperativa (VIG CZ), ČPP (VIG) | Hungary, Romania, Czechia | — |
Global reinsurers (Munich Re, Swiss Re, Hannover Re, SCOR) | External reinsurance (UNIQA Re) | Pricing setters in a softening market |
Peer Comparison FY2025
| Metric | UNIQA | VIG | PZU Group |
|---|---|---|---|
Gross written premiums | EUR 8.35bn | EUR 16.3bn | c.PLN 31bn |
Premium growth | 8.2% | 7.1% | — |
Pre-tax profit | EUR 516m | EUR 1,161m | — |
Net profit attributable | EUR 425m | EUR 835m | c.PLN 6.7bn |
Net combined ratio | 91.7% | 90.1% | — |
Solvency II ratio | c.275% | 296% | 234% |



